Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Tournier

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2018
A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain BarrierMartin Bauer, Rudolf Karch, Beatrix Wulkersdorfer, et al.
Toxins|February 12, 2021
Ricin Antibodies' Neutralizing Capacity against Different Ricin Isoforms and CultivarsMaria Lucia Orsini Delgado, Arnaud Avril, Julie Prigent, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet ImagingMalvika Sardana, Louise Breuil, Sébastien Goutal, et al.
Molecular Pharmaceutics|September 6, 2018
Effect of Rifampicin on the Distribution of [<sup>11</sup>C]Erlotinib to the Liver, a Translational PET Study in Humans and in MiceMartin Bauer, Alexander Traxl, Akihiro Matsuda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2019
Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate <sup>11</sup>C-Metoclopramide Assessed with PET Imaging in HumansNicolas Tournier, Martin Bauer, Verena Pichler, et al.
Molecular Pharmaceutics|January 15, 2026
Whole-Body Dynamic PET Imaging of Half-Life Extended Variable Domains of Heavy Chain-Only Antibodies: Beyond Blood PharmacokineticsEtienne Marchal, Sébastien Goutal, Mylène Richard, et al.
Fluids and Barriers of the CNS|October 28, 2024
[<sup>11</sup>C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patientsMyriam El Biali, Louise Breuil, Matthias Jackwerth, et al.
Clinical and Translational Science|May 3, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrierMyriam El Biali, Michael Wölfl-Duchek, Matthias Jackwerth, et al.
Neurobiology of Disease|November 3, 2024
Impaired brain glucose metabolism as a biomarker for evaluation of dodecyl creatine ester in creatine transporter deficiency: Insights from patient brain-derived organoids and in vivo [18F]FDG PET imaging in a mouse modelClémence Disdier, Amélie Soyer, Léa Broca-Brisson, et al.
Infection|January 2, 2021
Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strainEmmanuelle Billon-Denis, Audrey Ferrier-Rembert, Annabelle Garnier, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 22, 2018
A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood-Brain BarrierMartin Bauer, Rudolf Karch, Beatrix Wulkersdorfer, et al.
Toxins|February 12, 2021
Ricin Antibodies' Neutralizing Capacity against Different Ricin Isoforms and CultivarsMaria Lucia Orsini Delgado, Arnaud Avril, Julie Prigent, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2022
Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet ImagingMalvika Sardana, Louise Breuil, Sébastien Goutal, et al.
Molecular Pharmaceutics|September 6, 2018
Effect of Rifampicin on the Distribution of [<sup>11</sup>C]Erlotinib to the Liver, a Translational PET Study in Humans and in MiceMartin Bauer, Alexander Traxl, Akihiro Matsuda, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 12, 2019
Impact of P-Glycoprotein Function on the Brain Kinetics of the Weak Substrate <sup>11</sup>C-Metoclopramide Assessed with PET Imaging in HumansNicolas Tournier, Martin Bauer, Verena Pichler, et al.
Molecular Pharmaceutics|January 15, 2026
Whole-Body Dynamic PET Imaging of Half-Life Extended Variable Domains of Heavy Chain-Only Antibodies: Beyond Blood PharmacokineticsEtienne Marchal, Sébastien Goutal, Mylène Richard, et al.
Fluids and Barriers of the CNS|October 28, 2024
[<sup>11</sup>C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patientsMyriam El Biali, Louise Breuil, Matthias Jackwerth, et al.
Clinical and Translational Science|May 3, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrierMyriam El Biali, Michael Wölfl-Duchek, Matthias Jackwerth, et al.
Neurobiology of Disease|November 3, 2024
Impaired brain glucose metabolism as a biomarker for evaluation of dodecyl creatine ester in creatine transporter deficiency: Insights from patient brain-derived organoids and in vivo [18F]FDG PET imaging in a mouse modelClémence Disdier, Amélie Soyer, Léa Broca-Brisson, et al.
Infection|January 2, 2021
Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strainEmmanuelle Billon-Denis, Audrey Ferrier-Rembert, Annabelle Garnier, et al.
Pageof 20